Nomograms demonstrated strong predictive performance, with C-indexes around 0.70 to 0.72 and 5- and 10-year areas under the curve ranging from 0.713 to 0.759 in training and validation cohorts.

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.

Cancer surgery among patients older than 65 years is complex with high morbidity underscoring the need for specialized care at high-quality hospitals.

The most common adverse events reported in the neoadjuvant and adjuvant pembrolizumab plus enfortumab vedotin arm were pruritus, alopecia, diarrhea, fatigue and anemia. No new safety signals were ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

The risk of lung cancer varies among responders involved in rescue and recovery after the collapse of the World Trade Center, a study suggests.

Researchers successfully developed a machine learning-based method for predicting symptom deterioration in patients with cancer.

The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.

A cross-sectional study evaluated if the mode of sexual orientation and gender identification disclosure was associated with receiving clinical resources tailored to LGBTQ+ cancer survivors.

The combination of enzalutamide and leuprolide significantly improves overall survival among patients with prostate cancer and a high risk for biochemical recurrence, according to a study published ...

In vitro studies have suggested that BTKi therapy can suppress NOTCH1 activation via B-cell receptor–NOTCH1 interactions, providing a mechanistic rationale for these clinical results.

The TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) improved survival, compared with platinum-based chemotherapy, in patients with EGFR-mutated non-small cell lung cancer (NSCLC) ...